Ufp Technologies, Inc. · NASDAQ:UFPT

Ufp Technologies — Investor Presentation (June 2026)

14 slides from Ufp Technologies's investor presentation, Jun 8, 2026

  1. Slide 1: Welcome Investors June 2026

    Welcome Investors June 2026 1

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Some of the statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). Management and representat

  3. Slide 3: Investment Overview

    Investment Overview High Switching Costs Blue-Chip Customers Long Product Lifecycles Growing Segments UFP Technologies is a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom p

  4. Slide 4: Attractive Market Opportunity

    Attractive Market Opportunity Large, growing, regulated, and fragmented with serial innovation ~$518B Global Medical Device Market ~6.3% CAGR1 ~$100B Outsourcing Opportunity ~10% CAGR2 ~15+ Major Market Segments ~75 Sub-Segments Confidential, property of UFP Technologies, Inc. UFP's Core Focus on Pl

  5. Slide 5: What We Do: Development & Manufacturing Partner, Enabling Better Patient Outcomes

    What We Do: Development & Manufacturing Partner, Enabling Better Patient Outcomes Developing new innovations into long-term manufacturing revenue WHO WE SERVE Early Development Design, prototyping & regulatory strategy Scale & Optimize Drive innovation & take costs out Full Production Long-term manu

  6. Slide 6: What We Do: Turning Product Ideas into Reality with Material Technology

    What We Do: Turning Product Ideas into Reality with Material Technology Confidential, property of UFP Technologies, Inc. Surgical Site Sterile Barriers Access Port Catheter Surgical Screws Patient Beds Implants Robotic Drapes Patient Transfer Pacemaker RAS Patient Beds Cardiovascular Infection Contr

  7. Slide 7: Differentiation and Competitive Advantage

    Differentiation and Competitive Advantage Innovate and scale with engineering, material, and manufacturing expertise 1 Design In Early Ability to make technology available at the front-end of the process 2 Scale & Optimize Experience and trust to scale with a global platform 3 Durable Relationships

  8. Slide 8: Segment Focus

    Segment Focus Exposure to growth medical segments offering differentiated single-use technologies to improve patient outcomes and deliver value Confidential, property of UFP Technologies, Inc.Infection Control *Grand View Research, MarketsandMarkets, Transparency Market Research, Global Market Insig

  9. Slide 9: Strategy to Win

    and Strategy to Win Disciplined strategy designed to compound revenue and earnings through organic growth and customer-centric acquisitions Organic Growth • Differentiated material technologies in faster- growing segments • Early development partnerships that convert to manufacturing programs • Manu

  10. Slide 10: Proven Financial Performance

    Proven Financial Performance Consistent multi-year growth with meaningful margin expansion Confidential, property of UFP Technologies, Inc. $179 $218 $311 $428 $554 $603 10.0% 11.1% 13.8% 16.4% 18.3% 17.1% 0% 10% 20% 30% 40% 50% 60% 70% 0 100 200 300 400 500 600 700 2020 2021 2022 2023 2024 2025 Rev

  11. Slide 11: Clear Financial Framework and Capital Discipline

    Clear Financial Framework and Capital Discipline Clear financial targets supported by disciplined capital allocation and leverage philosophy 3–5 Year Financial Targets 12–18% Annual Revenue Growth 28–31% Gross Margins 17–20% Adj. Operating Margins Confidential, property of UFP Technologies, Inc. 11

  12. Slide 12: Experienced Management Team

    Experienced Management Team Deep MedTech expertise driving decentralized platform execution Mitch Rock President & CEO 33 yrs at UFP Ron Lataille CFO, SVP & Treasurer 29 yrs at UFP Ryan Stafford General Counsel & SVP HR Former EVP LFUS Jason Holt SVP Former ITW, 8 yrs at UFP Daniel Lee VP via DAS Me

  13. Slide 13: Why Invest Now?

    Why Invest Now? A High-Quality MedTech Platform Built to Compound Value Over Time Confidential, property of UFP Technologies, Inc. NASDAQ: UFPT investorinfo@ufpt.com www.ufpt.com Large, growing, fragmented market Differentiated technology embedded with customers Driving better patient outcomes and d

  14. Slide 14: Thank You!

    =—= UFP we TECHNOLOGIES Thank You! 4

UFP Technologies — Investor Presentation (June 2026) on 6ix